The estimated Net Worth of Tony M. Chou is at least $3.51 Milion dollars as of 1 February 2023. Tony Chou owns over 13,008 units of Silk Road Medical Inc stock worth over $2,062,259 and over the last 6 years he sold SILK stock worth over $1,324,070. In addition, he makes $120,404 as Independent Director at Silk Road Medical Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Tony Chou SILK stock SEC Form 4 insiders trading
Tony has made over 3 trades of the Silk Road Medical Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 13,008 units of SILK stock worth $715,440 on 1 February 2023.
The largest trade he's ever made was selling 13,008 units of Silk Road Medical Inc stock on 1 February 2023 worth over $715,440. On average, Tony trades about 2,189 units every 5 days since 2019. As of 1 February 2023 he still owns at least 75,707 units of Silk Road Medical Inc stock.
You can see the complete history of Tony Chou stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Tony Chou biography
Dr. Tony M. Chou M.D. serves as Independent Director of the Company. Dr. Chou has been a general partner at The Vertical Group, a healthcare-focused venture capital firm, since August 2006. After joining The Vertical Group, Dr. Chou co-founded our company in 2007 and served as Chief Executive Officer until November 2010. Prior to that, Dr. Chou had general management and business development responsibilities in the Abbott Vascular Division of Abbott Laboratories and last served as Division Vice President and General Manager of vascular closure, managing the FDA approval and global launch of the Perclose and Starclose products. Dr. Chou was previously the Director of the Adult Cardiac Catheterization Laboratory at the University of California, San Francisco, where he is currently Associate Professor of Medicine.
What is the salary of Tony Chou?
As the Independent Director of Silk Road Medical Inc, the total compensation of Tony Chou at Silk Road Medical Inc is $120,404. There are 11 executives at Silk Road Medical Inc getting paid more, with Erica Rogers having the highest compensation of $3,679,060.
How old is Tony Chou?
Tony Chou is 59, he's been the Independent Director of Silk Road Medical Inc since 2017. There are 2 older and 10 younger executives at Silk Road Medical Inc. The oldest executive at Silk Road Medical Inc is Jack Lasersohn, 66, who is the Independent Director.
What's Tony Chou's mailing address?
Tony's mailing address filed with the SEC is C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE, CA, 94089.
Insiders trading at Silk Road Medical Inc
Over the last 6 years, insiders at Silk Road Medical Inc have traded over $925,682,871 worth of Silk Road Medical Inc stock and bought 14,200 units worth $302,033 . The most active insiders traders include X Finance, L.P.Wpx Gp, L.P...., Pincus & Co.Kaye Charles R ... a Pincus & Co.Warburg Pincus .... On average, Silk Road Medical Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,280,712. The most recent stock trade was executed by Kevin M Klemz on 19 August 2024, trading 2,268 units of SILK stock currently worth $61,463.
What does Silk Road Medical Inc do?
silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th
What does Silk Road Medical Inc's logo look like?
Complete history of Tony Chou stock trades at Silk Road Medical Inc
Silk Road Medical Inc executives and stock owners
Silk Road Medical Inc executives and other stock owners filed with the SEC include:
-
Erica Rogers,
President, Chief Executive Officer, Director -
Lucas Buchanan,
Chief Financial Officer, Chief Operating Officer -
Andrew Davis,
Executive Vice President - Global Sales and Marketing -
Lucas W. Buchanan,
CFO & COO -
Andrew S. Davis,
Chief Commercial Officer -
Erica J. Rogers,
Pres, CEO & Director -
Richard M. Ruedy,
Exec. VP of Clinical, Regulatory Affairs & Quality Assurance -
Jack Lasersohn,
Independent Director -
Ruoxi Chen,
Independent Director -
Donald Zurbay,
Independent Director -
Elizabeth Weatherman,
Independent Director -
Tony Chou,
Independent Director -
Lynn Lewis,
IR Contact Officer -
Rick Anderson,
Director -
William Whealon,
Executive Vice President - Research and Development -
Richard Ruedy,
Executive Vice President - Regulatory Affairs, Clinical Affairs & Quality Assurance -
Dr. Sumaira MacDonald,
Exec. Medical Director -
Alison Highlander,
VP of HR -
Matthew McCarthy,
VP of Marketing -
William Hill,
Gen. Counsel -
Mhairi L. Jones,
VP of Fin. & Accounting -
Kevin M Klemz,
EVP/Chief Legal Officer/Sec. -
Pincus & Co.Warburg Pincus ...,
-
John E Runnells,
-
Richard B Emmitt,
-
Pincus & Co.Kaye Charles R ...,
-
Amr Kronfol,
Director -
Group Lp Vertical,
-
Venture Partners Xiii, Lp C...,
-
X Finance, L.P.Wpx Gp, L.P....,
-
Robert Mittendorff,
Director -
Pincus & Co.Warburg Pincus ...,
-
Kevin J. Ballinger,
-
Tanisha Carino,
-
Chas Mc Khann,
Chief Executive Officer -
Marie L. Jones,
VP, Finance and CAO